We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

By HospiMedica International staff writers
Posted on 26 May 2023
Print article
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts. In cardiac surgery, risk scores provided by The Society of Thoracic Surgeons (STS) are often used to evaluate a patient's procedural risk. While these scores remain vital for hospitals to assess and improve their performance, they are drawn from population-wide data, which can fall short of accurately predicting risk for specific patients with complex pathologies.

Now, cardiovascular surgeons and data science specialists at Mount Sinai (New York, NY, USA) have developed a machine learning-based model that predicts mortality risk for individual cardiac surgery patients, offering a considerable performance advantage over current population-based models. This data-driven algorithm, built on extensive electronic health records (EHR), is the first institution-specific model of its kind for pre-surgery cardiac patient risk assessment. It allows healthcare providers to determine the optimal treatment strategy for each patient.

The team theorized that models based on EHR data from their own institution, created via machine learning, could provide a useful solution. Using routinely gathered EHR data, they developed a robust machine learning framework to generate a risk prediction model for post-surgery mortality that is customized to both the patient and the hospital. This model incorporates vital data about Mount Sinai’s patient population, including demographic, socioeconomic, and health characteristics. This is in contrast to population-based models like STS, which rely on data from various health systems across the U.S. The effectiveness of this approach is further enhanced by an efficient open-source prediction algorithm called XGBoost, which assembles a group of decision trees by progressively focusing on harder-to-predict segments of training data.

The research team utilized XGBoost to model 6,392 cardiac surgeries conducted at The Mount Sinai Hospital from 2011 to 2016, encompassing heart valve procedures, coronary artery bypass grafts, aortic resections, replacements, or anastomoses, and reoperative cardiac surgeries, which significantly increase mortality risk. The team then compared the performance of their model to STS models for the same patient sets. The study found that the XGBoost model outshone STS risk scores for mortality in all frequently performed cardiac surgery categories for which STS scores were designed. The predictive performance of the XGBoost model across all types of surgeries was also high, indicating the potential of machine learning and EHR data for constructing effective institution-specific models.

“The standard-of-care risk models used today are limited by their applicability to specific types of surgeries, leaving out significant numbers of patients undergoing complex or combination procedures for which no models exist,” said senior author Ravi Iyengar, PhD, the Dorothy H. and Lewis Rosenstiel Professor of Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai, and Director of the Mount Sinai Institute for Systems Biomedicine. “Our team rigorously combined electronic health record data and machine learning methods to demonstrate for the first time how individual institutions can build their own risk models for post-cardiac surgery mortality.”

Related Links:
Mount Sinai 

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
Plug-In Patient Monitor
HT8
New
Wound Dressing
Thin Absorbent Wound Dressing Featuring TASA
New
IV Medication Safety Software
ICU Medical MedNet IV

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.